Loading…
Sunday, December 28, 2014
Current Weather
Loading Current Weather....
Published: Sunday, 6/28/2009

Forgotten killer

LUNG cancer kills more Americans than any other type of malignancy, claiming 162,000 lives every year. It is responsible for nearly one-third of all cancer deaths, yet, as the death toll climbs, research funding for this ferocious killer is lower than any other major cancer.

Logic would suggest that research dollars aimed at developing ways to detect and treat diseases would be targeting the worst killers, but that's not what's been happening. The National Institutes of Health, the primary funding agency for medical research, spent only 5 percent of its $4.8 billion budget in lung cancer research, according to the Lung Cancer Alliance, an advocacy group. Yet the disease caused 31 percent of the cancer deaths among men and 26 percent among women.

Few illnesses engender as little sympathy as lung cancer does for those afflicted with it because most lung cancer is caused by smoking. Cancer researchers believe that a "punishment mentality" underlies funding decisions for cancer research.

But there's plenty wrong with that thinking.

First, women who never smoked now make up the fastest-growing group of lung cancer patients. Second, blaming the victim offers no absolution to those who contract the disease through secondhand smoke, at no fault of their own. Third, society as a whole shares in the increased medical costs associated with treating its effects.

Unfortunately, there is no early-detection test for lung cancer, and 8 out of 10 cases are advanced by the time they are diagnosed. As a consequence, the five-year survival rate for lung cancer remains at about 16 percent, a figure that has been largely unchanged as survival rates for other cancers have seen significant improvements.

The solution is development of effective protocols for spotting these cancers before they inflict fatal damage, as well as devising treatments that will combat it.

That takes money, far more than has been directed to lung cancer research to date. But it is money well worth spending. Just ask those who have lost a loved one to lung cancer.



Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. If a comment violates these standards or our privacy statement or visitor's agreement, click the "X" in the upper right corner of the comment box to report abuse. To post comments, you must be a Facebook member. To find out more, please visit the FAQ.